1、A 25B Menopause and Longevity Opportunity MAY 22,2026 12 min readBy Johanna Benesty,Karin Schetelig,Anne Menegaux and Gudrun ZechnerBOSTON CONSULTING GROUPFROM INVISIBLE TO INVESTABLE 2Executive Summary2 NHS Confederation,CREATE Health Foundation&London Economics(2024).Womens Health Economics:Invest
2、ing in the 51 per cent3 DataInsights Market Research(2025).Consumer Trends in Menopause App Market 1 Fawcett Society&Channel 4(2022).Menopause and the Workplace.Survey of 4,014 UK women aged 4555Menopause is a natural biological transition experienced by every woman yet the hormonal changes it bring
3、s,particularly the sustained decline in estrogen,carry significant health consequences including elevated risk of cardiovascular disease,osteoporosis,depression,and cognitive decline that remain widely undertreated.Europes menopause treatment market is one of the most structurally underpenetrated op
4、portunities in healthcare.New BCG research across the UK,France and Germany reveals that only 28%of medically eligible women currently receive Hormone Replacement Therapy(HRT),and fewer than 2%of women who could benefit from non-hormonal prescription treatments are being treated today.The total addr
5、essable market across these three countries alone reaches 25B if all barriers to access were removed 5x todays 5B served market.Six findings stand out:185 million women in Europe are currently going through menopause,equaling roughly 25%of the total population.90%of women experience symptoms,yet few
6、er than one in four is receiving adequate care.The care gap is acute and costly.More than 65%of menopausal women report substantial quality-of-life impairment.In the UK around 20%of menopausal wom-en consider leaving their jobs due to symptoms,with 10%1 actually doing so,and unemployment linked to m